Follow The Filings

GNTX Gentex Corporation

Consumer Discretionary, filed as Gentex Corporation (COM), Equity As of 2026 Q3 so far: 135 of 140 managers we track have filed Quote on Google Finance, opens in a new tab

Bought by 2 managers in 2026 Q3, sold by 2

  • 3 Owners
  • Max 2.1%
  • $201M
  • 1 new 1 add 1 reduce 1 exit

In 2026 Q3 Glenview Capital Management opened a position in Gentex, John Rogers added, Jensen Investment Management trimmed, and Farallon Capital Management sold out.

Who owns this now

Largest portfolio weights among holders, up to 2.1% (John Rogers, Ariel Investments). Not free-float ownership.

  1. John Rogers Add 2.1%
  2. Jensen Investment Management Reduce 0.07%

Who owns GNTX

Sorted by value, long equity only, as of 2026 Q3.

History
John Rogers, Ariel Investments 2.1% Add +9.7% 9,115,866 $198M History
Jensen Investment Management 0.07% Reduce −8.8% 98,900 $2.2M History
Glenview Capital Management <0.01% New <0.01% 9,600 $209K History
Farallon Capital Management exited 2026 Q3 Last 2026 Q2 0.02% Exit −0.02% 199,000 $5M History

Weight bar: held both quarters added sold at this quarter’s reported price

Insider trades

Open-market buys and sales by GNTX's executives, directors and 10% owners in the last 12 months, from their Form 4s

All GNTX insider trades
  • None no insider bought on the open market
  • $2.8M sold by 9 insiders outside a trading plan
  • None no planned (10b5-1) sales
  1. Joseph B. Anderson Jr. Director
    Sale
    $136K 5,939 shares at $22.98 100% of stake
    Traded May 15 Filed May 15
  2. Leslie L. Brown Director
    Sale
    $246K 10,782 shares at $22.85 23% of stake
    Traded May 5 Filed May 5
  3. Richard O. Schaum Director
    Sale
    $112K 4,815 shares at $23.31 5.6% of stake
    Traded Apr 30 Filed Apr 30
  4. Neil Boehm Chief Technology Officer
    Sale
    $279K 11,248 shares at $24.82 16% of stake
    Traded Feb 17 Filed Feb 19
  5. Matthew Chiodo Vice President of Sales
    Sale
    $496K 19,827 shares at $25.03 36% of stake
    Traded Feb 17 Filed Feb 19
  6. Scott P. Ryan General Counsel
    Sale
    $223K 9,024 shares at $24.73 17% of stake
    Traded Feb 17 Filed Feb 19
  7. Steven R. Downing CEO
    Sale
    $866K 35,000 shares at $24.75 14% of stake
    Traded Feb 17 Filed Feb 19
  8. Kevin C. Nash CFO
    Sale
    $297K 11,885 shares at $24.98 17% of stake
    Traded Feb 17 Filed Feb 19

Also filed in the last 12 months, not counted as buying or selling: 18 stock grants, 10 share withholdings for taxes, and 3 option exercises.

Congress

1 member of Congress traded GNTX in the last three years: 0 buys and 1 sale.

All Congress trades
  1. Tommy Tuberville R-ALJoint Sell $15K–$50K Jan 19, 2024 filed Feb 14, 2024

SEC filings

Recent issuer filings from EDGAR, 21 shown.

Filed Form Detail Links
10-Q
8-K 2.02,9.01
SCHEDULE 13G —
SCHEDULE 13G —
10-Q
8-K 2.02,9.01
8-K 5.07
10-Q
SCHEDULE 13G —
8-K 2.02,9.01
DEF 14A
DEFA14A
SCHEDULE 13G/A —
10-K
SCHEDULE 13G/A —
8-K 2.02,9.01
10-Q
8-K 2.02,9.01
SCHEDULE 13G/A —
10-Q
8-K 2.02,9.01

Financials

US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.

Income statement

Metric FY2023 FY2024 FY2025
Revenue $2.3B $2.31B $2.53B
Gross profit $762.63M $771.09M $866.71M
Gross margin * 33.2% 33.3% 34.2%
Net income $428.4M — $384.84M
Net margin * 18.6% — 15.2%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $0.998B $1.04B $1.13B
Total non-current assets * $1.61B $1.72B $1.8B
Total assets $2.61B $2.76B $2.93B
Total current liabilities $271.61M $252.69M $387.54M
Total non-current liabilities * $27.31M $36.03M $50.12M
Total equity $2.31B $2.47B $2.49B

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations $537.25M $498.21M $587.13M
Cash from investing -$299.42M -$202.08M -$266.9M
Cash from financing -$230.15M -$289.25M -$407.9M
Net change in cash $7.68M $6.88M -$87.67M

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.

Further reading

As an Amazon Associate, FollowTheFilings earns from qualifying purchases.

More on the shelf